McGregor Grant, BEc, cA, GAICD, FGIA, FCIS

McGregor joined the Board in September 2023 and was appointed as Chair at that time. He was appointed as Executive Chair and interim CFO in November 2023.

Mr. Grant has over 26 years’ experience in the medical device and healthcare industries in Australia and the United States. Most recently, Mr. Grant was the CFO and Company Secretary of Nanosonics Limited. In that role he gained extensive commercial experience leading Nanosonics from start up through growth and business maturation to become a successful global business with operations in North America, Europe and Asia Pacific. Mr. Grant has extensive international experience gained with Invacare as the Asia Pacific Finance Director, and Abbott Laboratories in a number of senior finance roles located in Australia and the United States. Previously Mr. Grant worked for Coopers & Lybrand (now PwC) in Australia and Europe.